Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL315 Target Snapshot

Alpha-1B adrenergic receptor · SINGLE PROTEIN · Rattus norvegicus

1,424Compounds
109Assays
135Approved Drugs
1,922.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P15823. Use UniProt P15823 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P15823 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Alpha-1B adrenergic receptor as ChEMBL target CHEMBL315, mapped to UniProt P15823. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Alpha-1B adrenergic receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL315
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P15823
Alpha-1B adrenergic receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Alpha-1B adrenergic receptor is the right protein anchor across sources, using UniProt P15823 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAlpha-1B adrenergic receptor
UniProt AccessionP15823
Component TypeProtein
Sequence Length515 aa

Alpha-1B adrenergic receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Alpha-1B adrenergic receptor, mapped to UniProt P15823. Sequence length is 515 aa.

Mapped IDP15823
Review nameAlpha-1B adrenergic receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

135
Approved
10
Phase III
13
Phase II
Assay Mix

Activity Type Distribution

IC50864.0
KI918.0
EC5019.0
KD121.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1259128 10.0 Ki 0.1 Preclinical
CHEMBL2 10.0 Ki 0.099 Approved
CHEMBL27013 9.84 Kd 0.1445 Preclinical
CHEMBL1259216 9.82 Ki 0.15 Preclinical
CHEMBL1259129 9.82 Ki 0.15 Preclinical
CHEMBL2 9.75 IC50 0.178 Approved
CHEMBL1558 9.72 IC50 0.19 Approved
CHEMBL836 9.69 Kd 0.2042 Approved
CHEMBL217469 9.69 Kd 0.2042 Preclinical
CHEMBL2261604 9.68 Ki 0.2089 Preclinical
Distribution

pChEMBL Value Distribution

17
5.0
43
5.5
41
6.0
45
6.5
54
7.0
39
7.5
48
8.0
43
8.5
19
9.0
17
9.5
pChEMBL
Approved Drugs

Approved Drugs

SILODOSIN
CHEMBL24778
Approved 2008
ALFUZOSIN
CHEMBL709
Approved 2003
NAFTOPIDIL
CHEMBL142635
Approved 1999
SILDENAFIL
CHEMBL192
Approved 1998
QUETIAPINE
CHEMBL716
Approved 1997
TAMSULOSIN
CHEMBL836
Approved 1997
OLANZAPINE
CHEMBL715
Approved 1996
CARVEDILOL
CHEMBL723
Approved 1995
RISPERIDONE
CHEMBL85
Approved 1993
CISAPRIDE
CHEMBL1729
Approved 1993
SERTRALINE
CHEMBL809
Approved 1991
DAPIPRAZOLE
CHEMBL1201216
Approved 1990
DOXAZOSIN
CHEMBL707
Approved 1990
EBASTINE
CHEMBL305660
Approved 1990
CLOZAPINE
CHEMBL42
Approved 1989
CLOMIPRAMINE
CHEMBL415
Approved 1989
ASTEMIZOLE
CHEMBL296419
Approved 1988
TERAZOSIN
CHEMBL611
Approved 1987
OXYMETAZOLINE
CHEMBL762
Approved 1986
LABETALOL
CHEMBL429
Approved 1984
PENTAMIDINE
CHEMBL55
Approved 1984
GUANABENZ
CHEMBL420
Approved 1982
TRAZODONE
CHEMBL621
Approved 1981
VERAPAMIL
CHEMBL6966
Approved 1981
AMOXAPINE
CHEMBL1113
Approved 1980
MAPROTILINE
CHEMBL21731
Approved 1980
BROMOCRIPTINE
CHEMBL493
Approved 1978
DOBUTAMINE
CHEMBL926
Approved 1978
CLEMASTINE
CHEMBL1626
Approved 1977
PRAZOSIN HYDROCHLORIDE
CHEMBL1558
Approved 1976
LOPERAMIDE
CHEMBL841
Approved 1976
PRAZOSIN
CHEMBL2
Approved 1976
DROPERIDOL
CHEMBL1108
Approved 1970
DOXEPIN
CHEMBL1628227
Approved 1969
HALOPERIDOL
CHEMBL54
Approved 1967
EPINEPHRINE
CHEMBL679
Approved 1965
NORTRIPTYLINE
CHEMBL445
Approved 1964
THIORIDAZINE
CHEMBL479
Approved 1962
CYPROHEPTADINE
CHEMBL516
Approved 1961
AMITRIPTYLINE
CHEMBL629
Approved 1961
FLUPHENAZINE
CHEMBL726
Approved 1959
CHLORPROMAZINE
CHEMBL71
Approved 1957
PROCHLORPERAZINE
CHEMBL728
Approved 1956
PROMAZINE
CHEMBL564
Approved 1956
BENZTROPINE
CHEMBL1201203
Approved 1954
PHENTOLAMINE
CHEMBL597
Approved 1952
PROMETHAZINE
CHEMBL643
Approved 1951
ERGOTAMINE
CHEMBL442
Approved 1948
DIHYDROERGOTAMINE
CHEMBL1732
Approved 1946
Assay Landscape

Assay Landscape

109
Total Assays
192
Tested Compounds
3
Assay Types
Binding — 68 assays, 192 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 31 41 6.7
assay format 14 27 7.8
tissue-based format 14 14 7.6
cell membrane format 9 110 7.0
Functional — 39 assays, 92 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 34 72 7.8
assay format 5 20 7.3
ADME — 2 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 2 1 7.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine